Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cyanotech Corp (CYAN)

Cyanotech Corp (CYAN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2023

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the third quarter and...

CYAN : 0.2906 (-1.72%)
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2023

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the second quarter...

CYAN : 0.2906 (-1.72%)
ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS

/PRNewswire/ -- Anavasi Diagnostics ('Anavasi'), an NIH/RADx medical technology company focused on the development of novel molecular diagnostic testing,...

LQDA : 12.79 (-1.46%)
CYAN : 0.2906 (-1.72%)
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2023

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of...

CYAN : 0.2906 (-1.72%)
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2022

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the fourth quarter...

CYAN : 0.2906 (-1.72%)
Nutrex Hawaii Launches New Product, TurmericAstin®

Nutrex Hawaii, Inc. is proud to announce its new product launch of TurmericAstin ® - a powerful combination of two of nature’s most powerful antioxidants, BioAstin® Hawaiian Astaxanthin® and Organic...

CYAN : 0.2906 (-1.72%)
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the third quarter and...

CYAN : 0.2906 (-1.72%)
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2022

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the second quarter...

CYAN : 0.2906 (-1.72%)
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2022

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of...

CYAN : 0.2906 (-1.72%)
Astaxanthin Market Expected to Exceed $1.2 Billion By 2026 Leading the Nutraceutical Segment for Lucrative Growth

Palm Beach, FL – July 1, 2021 Astaxanthin may be the most important, potent supplements that most people don’t even know exists.  Astaxanthin is a powerful, naturally occurring carotenoid pigment...

PBIO : 0.2210 (-11.60%)
CYAN : 0.2906 (-1.72%)
PRGO : 32.79 (-0.82%)
MED : 26.69 (+2.93%)
ADM : 59.17 (-0.30%)

Barchart Exclusives

2 Uranium Stocks With 50% or More Upside Potential
As U.S. passes the bill to ban uranium import from Russia, U.S. based uranium companies are sure to enjoy the increased demand. Here are 2 stocks with upside according to analysts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar